US equity markets continued to show momentum last week and posted slight gains on Tuesday after the extended Christmas weekend.
At the close, the Dow Jones grew by less than 0.1% to 19.945 points, after rising to 19.980.2 points. ‘The’ blue chip ‘index ended the session at less than 60 points from the fateful 20,000 point mark,’ said Wells Fargo Advisors.
The high-tech Nasdaq composite gained nearly 0.5% at 5,487.4 points, while the S & P500 finished the session on a 0.2% gain at 2,288.9 points.
Volumes were once again shown to be relatively limited in the absence of a large number of operators and factors likely to feed a clear trend.
It seems, however, that markets continued to benefit from the Trump effect, which has been steadily increasing since the surprise election of the new President of the United States.
Published at the beginning of the session, the Conference Board’s US Consumer Confidence Index rose again to 113.7, compared with 109.4 in November, while economists averaged only 109.8 in December .
In terms of values, Biogen advanced 1.2% while the Food and Drug Administration (FDA) approved Spinraza in the treatment of spinal muscular atrophy.
The Nvidia share was up 6.9%, bringing its earnings up to around 250% since the beginning of the year, thanks to favorable comments from analysts.
Copyright (c) 2016 CercleFinance.com. All rights reserved.